A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a) OCEAN(a)-Outcomes- Olpasiran trials
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Amgen, Inc.
Start Date
May 10, 2023
End Date
May 31, 2028
Administered By
Institutes and Centers
Awarded By
Amgen, Inc.
Start Date
May 10, 2023
End Date
May 31, 2028